Pertussis in Asia: Recent country-specific data and recommendations.


Journal

Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899

Informations de publication

Date de publication:
16 02 2022
Historique:
received: 08 03 2021
revised: 30 10 2021
accepted: 02 12 2021
pubmed: 26 1 2022
medline: 15 2 2022
entrez: 25 1 2022
Statut: ppublish

Résumé

The Global Pertussis Initiative (GPI) Roundtable Meeting held in 2019, which preceded the COVID-19 pandemic, focused on the incidence, surveillance, and immunization practices for pertussis in the Asian region. Participants from China, India, Indonesia, Malaysia, Pakistan, Philippines, South Korea, Taiwan, and Thailand presented country-specific information on pertussis prevalence, diagnosis, surveillance, vaccine administration and schedules, maternal and neonatal disease rates, and policies and practice of vaccination during pregnancy. In recent years, many Asian countries have seen an increase in pertussis cases, although underreporting of the disease is a concern. Currently, most Asian countries have only passive surveillance for pertussis in place. There is a need for improved surveillance to determine the disease burden and justify vaccination policies and recommendations, such as essential vaccination, boosters, and vaccination during pregnancy. Better awareness of the disease in adolescents and adults is necessary, and infant and childhood vaccination schedules need to be improved in many countries. Differences between private versus public sector vaccination schedules and between whole-cell and acellular pertussis vaccines should continue to be examined. It can be anticipated that unmet needs in the prevention and management of pertussis will continue as the COVID-19 pandemic evolves and that key recommendations highlighted in this meeting report will be of ongoing importance.

Identifiants

pubmed: 35074239
pii: S0264-410X(21)01612-1
doi: 10.1016/j.vaccine.2021.12.004
pii:
doi:

Substances chimiques

Pertussis Vaccine 0

Types de publication

Congress Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1170-1179

Informations de copyright

Copyright © 2021. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Pramod Jog (P)

D.Y. Patil Medical College, Pune, India.

Iqbal Ahmad Memon (IA)

Sir Syed College of Medical Sciences for Girls, Karachi, Pakistan.

Usa Thisyakorn (U)

Tropical Medicine Cluster, Chulalongkorn University, Bangkok, Thailand. Electronic address: usa.thi@mahidol.ac.th.

Daniela Hozbor (D)

Instituto de Biotecnología y Biología Molecular, Facultad de Ciencias Exactas, Universidad Nacional de La Plata, La Plata, Argentina.

Ulrich Heininger (U)

Department of Infectious Diseases and Vaccinology, University of Basel Children's Hospital, Basel, Switzerland.

Carl Heinz Wirsing von König (CHW)

Independent Consultant, Krefeld, Germany.

Tina Tan (T)

Feinberg School of Medicine of Northwestern University, Chicago, IL, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH